Zhang Di, Wei Wanyu, Xie Tianxiang, Zhou Xue, He Xu, Qiao Jie, Guo Rui, Jin Gang, Li Ningbo
School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, China.
School of Stomatology, Shanxi Medical University, Taiyuan 030001, China.
ACS Omega. 2024 Dec 4;9(50):49749-49758. doi: 10.1021/acsomega.4c08267. eCollection 2024 Dec 17.
In this study, the mesoporous FeO nanodrug carriers containing disulfide bonds (CHO-SMNPs) were successfully synthesized and characterized. Doxorubicin (DOX) was loaded onto the CHO-SMNPs as a model drug and gatekeeper through the formation of imine bonds with the aldehyde groups on the surface of the mesoporous materials. This drug carrier demonstrates effective drug release triggered by pH, glutathione (GSH), and near-infrared (NIR) light, along with satisfactory photothermal conversion efficiency under NIR irradiation at 808 nm. Furthermore, CHO-SMNPs exhibit excellent blood compatibility and biodegradability. They also show good biocompatibility and efficient cellular uptake in HeLa and MCF-7 cancer cells. Most importantly, the CHO-SMNPs/DOX has shown significant effectiveness in killing both HeLa and MCF-7 cancer cells. Consequently, CHO-SMNPs/DOX presents substantial potential as a magnetic-targeted, pH/GSH/NIR triple-triggered drug delivery system for synergistic chemo-photothermal therapy in tumor treatment.
在本研究中,成功合成并表征了含二硫键的介孔FeO纳米药物载体(CHO-SMNPs)。阿霉素(DOX)作为模型药物和门控剂,通过与介孔材料表面的醛基形成亚胺键负载到CHO-SMNPs上。这种药物载体表现出由pH、谷胱甘肽(GSH)和近红外(NIR)光触发的有效药物释放,以及在808nm近红外照射下令人满意的光热转换效率。此外,CHO-SMNPs表现出优异的血液相容性和生物降解性。它们在HeLa和MCF-7癌细胞中也显示出良好的生物相容性和高效的细胞摄取。最重要的是,CHO-SMNPs/DOX在杀死HeLa和MCF-7癌细胞方面已显示出显著效果。因此,CHO-SMNPs/DOX作为一种用于肿瘤治疗中协同化疗-光热疗法的磁靶向、pH/GSH/NIR三重触发药物递送系统具有巨大潜力。
Colloids Surf B Biointerfaces. 2020-6
J Colloid Interface Sci. 2017-8-16
Colloids Surf B Biointerfaces. 2020-11
Int J Biol Macromol. 2023-7-1
Front Pharmacol. 2023-2-16
Adv Drug Deliv Rev. 2022-10